Literature DB >> 17678559

Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom.

J McVernon1, M E Ramsay, A R McLean.   

Abstract

A rise in invasive Haemophilus influenzae type b (Hib) infections occurred 8 years after vaccine introduction in the United Kingdom. Aspects of Hib vaccine delivery unique to the United Kingdom have been implicated. The authors developed a fully age-structured deterministic susceptible-infected-resistant-susceptible mathematical model, expressed as a set of partial differential equations, to better understand the causes of declining vaccine effectiveness. We also investigated the consequences of the vaccine's impact on reducing Hib transmission for maintenance of immunity. Our findings emphasized the importance of maintaining high post-immunization antibody titres among age groups at greatest risk of invasive infections. In keeping with UK population-based estimates, low direct efficacy of immunological memory against disease was found, cautioning against over-reliance on evidence of priming alone as a correlate of population protection. The contribution of herd immunity to disease control was reinforced. Possible intervention strategies will be explored in subsequent work.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17678559      PMCID: PMC2870866          DOI: 10.1017/S0950268807009168

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  54 in total

1.  Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration.

Authors:  J Fernandez; O S Levine; J Sanchez; S Balter; L LaClaire; J Feris; S Romero-Steiner
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

2.  Hib immunisation catch up programme in North East Thames.

Authors:  H O'Brien
Journal:  Commun Dis Rep CDR Rev       Date:  1994-02-04

3.  Population biology, evolution, and immunology of vaccination and vaccination programs.

Authors:  M E Halloran; R M Anderson; R S Azevedo-Neto; W J Bellini; O Branch; M A Burke; R Compans; K Day; L Gooding; S Gupta; J Katz; O Kew; H Keyserling; R Krause; A A Lal; E Massad; A R McLean; P Rosa; P Rota; P Wiener; S G Wynn; D M Zanetta
Journal:  Am J Med Sci       Date:  1998-02       Impact factor: 2.378

4.  Impact of vaccination on the spatial correlation and persistence of measles dynamics.

Authors:  B M Bolker; B T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Effect of combination with an acellular pertussis, diphtheria, tetanus vaccine on antibody response to Hib vaccine (PRP-T).

Authors:  F Bell; P Heath; F Shackley; J MacLennan; N Shearstone; L Diggle; H Griffiths; E R Moxon; A Finn
Journal:  Vaccine       Date:  1998-04       Impact factor: 3.641

6.  Immunological response to conjugate vaccines in infants: follow up study.

Authors:  D Goldblatt; E Miller; N McCloskey; K Cartwright
Journal:  BMJ       Date:  1998-05-23

7.  Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.

Authors:  D Goldblatt; A R Vaz; E Miller
Journal:  J Infect Dis       Date:  1998-04       Impact factor: 5.226

8.  Mechanism of antibody-mediated reduction of nasopharyngeal colonization by Haemophilus influenzae type b studied in an infant rat model.

Authors:  M Kauppi-Korkeila; L van Alphen; D Madore; L Saarinen; H Käyhty
Journal:  J Infect Dis       Date:  1996-12       Impact factor: 5.226

9.  Antibodies to Haemophilus influenzae type b polysaccharide affect bacterial adherence and multiplication.

Authors:  L van Alphen; P Eijk; H Käyhty; J van Marle; J Dankert
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines.

Authors:  J B Robbins; R Schneerson; P Anderson; D H Smith
Journal:  JAMA       Date:  1996-10-09       Impact factor: 56.272

View more
  4 in total

1.  Modeling insights into Haemophilus influenzae type b disease, transmission, and vaccine programs.

Authors:  Michael L Jackson; Charles E Rose; Amanda Cohn; Fatima Coronado; Thomas A Clark; Jay D Wenger; Lisa Bulkow; Michael G Bruce; Nancy E Messonnier; Thomas W Hennessy
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

2.  Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt.

Authors:  Sara Tartof; Amanda Cohn; Félix Tarbangdo; Mamoudou H Djingarey; Nancy Messonnier; Thomas A Clark; Jean Ludovic Kambou; Ryan Novak; Fabien V K Diomandé; Isaïe Medah; Michael L Jackson
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

Review 3.  Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction.

Authors:  S Georges; A Lepoutre; H Dabernat; D Levy-Bruhl
Journal:  Epidemiol Infect       Date:  2013-02-21       Impact factor: 4.434

4.  Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b.

Authors:  Nadia A Charania; Seyed M Moghadas
Journal:  BMC Public Health       Date:  2017-09-13       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.